Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A multi-centre study on the performance of the molecular genotyping platform ID RHD XT for resolving serological weak RhD phenotype in routine clinical practice.

Vox sanguinis - 1 Apr 2020

Londero Donatella, Monge Jorge, Hellberg Asa

Abstract excerpt

BACKGROUND AND OBJECTIVES: There is concern regarding the lack of prevention of unnecessary transfusion of RhD negative red cells and unnecessary administration of Rh immunoglobulin (RhIG) to pregnant women. In this study, performance of ID RHD XT, a genotyping assay for identification of six RHD allelic variants and human platelet antigens HPA-1a/1b was assessed. MATERIALS AND METHODS: Whole blood samples...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Antigens, Human Platelet

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotyping Techniques

Share to Infant, Newborn

Share to Integrin beta3

Share to Pregnancy

Share to Rh-Hr Blood-Group System

Share to Rho(D) Immune Globulin

Source

Identifiers

PMID: 31912520
DOI: 10.1111/vox.12886

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A multi-centre study on the performance of the molecular genotyping platform ID RHD XT for resolving serological weak RhD phenotype in routine clinical practice.PMID 31912520Read ↗

Performance evaluation study of ID RHD XT, a new genotyping assay for the detection of high-prevalence RhD negative and weak D types.Semantic proximity Read ↗

Investigation of discrepancies obtained during 15 years of non-invasive fetal RHD genotyping in apparent serologic RhD-negative pregnant women.Semantic proximity Read ↗

Serological weak D phenotypes: a review and guidance for interpreting the RhD blood type using the RHD genotype.Semantic proximity Read ↗

RHD genotyping to resolve weak and discrepant RhD patient phenotypes.Semantic proximity Read ↗

Impact of RHD genotyping on transfusion practice in Denmark and the United States and identification of novel RHD alleles.Semantic proximity Read ↗

Relevance and costs of RHD genotyping in women with a weak D phenotype.Semantic proximity Read ↗

RHD alleles among pregnant women with serologic discrepant weak D phenotypes from a multiethnic population and risk of alloimmunization.Semantic proximity Read ↗

Diverse and novel RHD variants in Australian blood donors with a weak D phenotype: implication for transfusion management.Semantic proximity Read ↗

Establishment of a medium-throughput approach for the genotyping of RHD variants and report of nine novel rare alleles.Semantic proximity Read ↗

Novel intronic RHD variants identified in serologically D-negative blood donors.Semantic proximity Read ↗

Obstetric and Newborn Weak D-Phenotype RBC Testing and Rh Immune Globulin Management Recommendations: Lessons From a Blinded Specimen-Testing Survey of 81 Transfusion Services.Semantic proximity Read ↗

Policies and procedures related to testing for weak D phenotypes and administration of Rh immune globulin: results and recommendations related to supplemental questions in the Comprehensive Transfusion Medicine survey of the College of American Pathologists.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.